A recent report has shown that olaparib induces ROS in bladder cancer cells,43 therefore, we also determined whether ROS levels were elevated in our olaparib-treated ATM-deficient A549 cells using a fluorescence-based assay. The gene discussed is ATM; the disease is urinary bladder carcinoma.